Pharmaceutical Business review

Oxis appoints David Saloff as CEO

In his career, he has founded three companies, two of which went public and a third that was sold to a healthcare products company.

Saloff was the co-founder and co-chief executive officer of Ivivi Technologies, which developed and manufactured advanced non-drug anti-inflammatory devices to treat chronic and acute wounds and post-surgical pain.

Oxis Chairman Anthony Cataldo said in addition to his managerial experience, David has an outstanding track record of effectively raising and deploying capital, and building shareholder value.

 

 

Exit mobile version